Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q3 2025 ▲▼ | Q4 2025 ▲▼ | Change ▲▼ | Q3 2025 ▲▼ | Q4 2025 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Zenas BioPharma, Inc.(ZBIO) | 4,911,539 | 5,037,854 | +126,315 | $109.04M | $182.92M | 25.90% | +$73.89M |
| Arcellx, Inc. COMMON STOCK | 2,346,630 | 2,346,630 | 0 | $192.66M | $153.00M | 21.66% | -$39.66M |
| CRISPR Therapeutics AG(CRSP) | 2,038,763 | 2,038,763 | 0 | $132.13M | $106.91M | 15.14% | -$25.22M |
| Design Therapeutics, Inc.(DSGN) | 6,526,476 | 6,526,476 | 0 | $49.14M | $61.22M | 8.67% | +$12.07M |
| Mineralys Therapeutics, Inc.(MLYS) | 2,113,933 | 1,563,966 | -549,967 | $80.16M | $56.76M | 8.03% | -$23.40M |
| ARS Pharmaceuticals, Inc.(SPRY) | 4,012,903 | 4,012,903 | 0 | $40.33M | $46.75M | 6.62% | +$6.42M |
| ORIC Pharmaceuticals, Inc.(ORIC) | 4,514,929 | 4,514,929 | 0 | $54.18M | $37.75M | 5.34% | -$16.43M |
| Alumis Inc. | 1,959,896 | 1,959,896 | 0 | $7.82M | $19.13M | 2.71% | +$11.31M |
| Oruka Therapeutics, Inc.(ORKA) | 430,330 | 430,330 | 0 | $8.28M | $13.04M | 1.85% | +$4.77M |
| Oculis Holding AG(OCS) | 322,500 | 641,022 | +318,522 | $5.67M | $12.80M | 1.81% | +$7.13M |
| enGene Holdings Inc. COM | 747,750 | 747,750 | 0 | $5.11M | $6.75M | 0.96% | +$1.65M |
| Nkarta, Inc.(NKTX) | 3,333,333 | 3,333,333 | 0 | $6.90M | $6.17M | 0.87% | -$733.3K |
| Ultragenyx Pharmaceutical Inc.(RARE) | 0 | 137,753 | +137,753 | $0 | $3.17M | 0.45% | +$3.17M |